相关实验视频
Updated: Mar 6, 2026
04:09
Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
Published on: September 20, 2024
1.1K
血交换有助于甲状腺切除在耐火性阿米奥达龙诱导的甲状腺毒性,尽管可变的生化反应
Michelle Maher1, Robert McEvoy1, Vanessa Farnan1
1Department of Endocrinology, Beaumont Hospital, Dublin 9, Ireland.
European thyroid journal
|March 5, 2026
概括
治疗性血交换 (TPE) 为阿米奥达龙诱导的甲状腺毒性病 (AIT) 提供了暂时的生化改善,有助于甲状腺切除术的准备. 虽然TPE看起来很有前途,但它的效果可能不一致,因此甲状腺切除术不应推迟.
科学领域:
- 内分泌学 在内分泌学.
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 阿米奥达龙诱导的甲状腺毒性病 (AIT) 呈现出显著的发病率和死亡率.
- 耐药性AIT病例往往对标准疗法反应有限.
- 治疗性血交换 (TPE) 被探索为甲状腺切除术的桥梁,但协议和反应定义各不相同.
研究的目的:
- 评估TPE在为甲状腺切除术准备重度耐火性AIT患者的疗效和安全性.
- 描述TPE在AIT患者中的生物化学和临床影响.
- 评估TPE作为AIT的辅助疗法.
主要方法:
- 四名患有严重耐火性AIT的患者接受了3-5次TPE疗程.
- 替代液体包括与盐溶液或新鲜冷血 (FFP) 结合的专蛋白.
- 生物化学标志物 (FT4,TT4,TSH) 和临床结果进行了监测.
主要成果:
- TPE导致自由甲状腺素 (FT4) 和总甲状腺素 (TT4) 水平的变量减少.
- 在大多数患者中,甲状腺刺激激素 (TSH) 水平在1-2次治疗后升至可检测的范围.
- 一般来说,TPE耐受性很好,有两个病例出现过渡性凝血病变和血小板狭窄. 所有患者都成功接受了甲状腺切除术,并实现了顺利甲状腺功能.
结论:
- 在耐火性AIT中,TPE可以提供暂时的生化改善和临床稳定,从而促进甲状腺切除术.
- TPE的生化作用可能是不一致的和短暂的;像凝血病这样的并发症需要监测.
- 对于精选的AIT患者来说,TPE是一种有价值的辅助物,但在甲状腺激素水平完全正常化之前,甲状腺切除不应推迟.
相关概念视频
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
2.8K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.8K
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
1.1K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.1K
01:25Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
299
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
299
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
730
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
730
01:26Heart Failure Drugs: Inotropic Agents
1.7K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.7K
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
294
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
294